Post-quantum cryptographic techniques for message transformation can be applied to secure the transmission of sensitive transcriptomic data in Multiple Sclerosis research across distributed networks.
Adversarial Debate Score
68% survival rate under critique
Model Critiques
Supporting Research Papers
- A Physically-Informed Subgraph Isomorphism Approach to Molecular Docking Using Quantum Annealers
Molecular docking is a crucial step in the development of new drugs as it guides the positioning of a small molecule (ligand) within the pocket of a target protein. In the literature, a feasibility st...
- Resource-efficient Quantum Algorithms for Selected Hamiltonian Subspace Diagonalization
Quantum algorithms for selecting a subspace of Hamiltonians to diagonalize have emerged as a promising alternative to variational algorithms in the NISQ era. So far, such algorithms, which include the...
- Onset of Ergodicity Across Scales on a Digital Quantum Processor
Understanding how isolated quantum many-body systems thermalize remains a central question in modern physics. We study the onset of ergodicity in a two-dimensional disordered Heisenberg Floquet model ...
- Machine Learning for analysis of Multiple Sclerosis cross-tissue bulk and single-cell transcriptomics data
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system whose molecular mechanisms remain incompletely understood. In this study, we developed an end-to-end machine learn...
- Universal Persistent Brownian Motions in Confluent Tissues
Biological tissues are active materials whose non-equilibrium dynamics emerge from distinct cellular force-generating mechanisms. Using a two-dimensional active foam model, we compare the effects of t...
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.
This discovery has a Claude-generated validation package with a full experimental design.
Precise Hypothesis
Post-quantum cryptographic (PQC) algorithms — specifically lattice-based (e.g., CRYSTALS-Kyber/CRYSTALS-Dilithium, NIST PQC Round 3 finalists) and hash-based (e.g., SPHINCS+) schemes — can encrypt, sign, and transmit RNA-seq transcriptomic datasets (≥10,000 gene features, ≥50 patient samples) characteristic of Multiple Sclerosis (MS) research across geographically distributed nodes with: (a) no statistically significant loss of data integrity (bit-error rate = 0), (b) end-to-end latency overhead ≤15% compared to classical AES-256/RSA-2048 baselines, (c) computational overhead ≤3× classical methods on commodity hardware, and (d) resistance to both classical and quantum adversarial attacks as defined by NIST security levels I–V.
- INTEGRITY FAILURE: Any non-zero bit-error rate in decrypted transcriptomic data across ≥3 independent transfer trials constitutes disproof of practical applicability.
- LATENCY FAILURE: End-to-end transfer latency overhead exceeds 50% over AES-256 baseline for datasets ≥10 GB in ≥5 of 10 trials.
- COMPUTATIONAL INFEASIBILITY: Key generation, encapsulation, or decapsulation time exceeds 60 seconds per 1 GB data chunk on reference hardware (Intel Xeon 3.0 GHz, 8 cores), making clinical workflows impractical.
- SECURITY BREAK: A published attack reduces effective security of Kyber-768 below 128-bit classical equivalent within the study period.
- SCALABILITY COLLAPSE: System throughput degrades super-linearly (>O(n²)) with number of distributed nodes (tested at n = 2, 5, 10, 20, 50).
- DATA UTILITY LOSS: Post-decryption differential gene expression (DGE) analysis yields statistically different results (FDR-adjusted p < 0.05, >1% gene set affected) compared to unencrypted baseline, indicating data corruption.
- KEY MANAGEMENT FAILURE: Certificate/key exchange failure rate >0.1% across 1,000 simulated connection attempts in adversarial network conditions.
Experimental Protocol
PHASE 1 — Baseline Characterization (Days 1–15): Establish performance benchmarks for classical cryptography (AES-256-GCM + RSA-2048) on MS transcriptomic datasets. Measure throughput, latency, CPU utilization, and memory consumption.
PHASE 2 — PQC Implementation and Unit Testing (Days 16–35): Implement PQC pipeline using liboqs (Open Quantum Safe library) with Kyber-768 for key encapsulation and Dilithium3 for digital signatures. Unit test on synthetic RNA-seq data (simulated via polyester R package).
PHASE 3 — Integration Testing on Real MS Data (Days 36–60): Apply PQC pipeline to publicly available MS transcriptomic datasets (GEO accession GSE138614, n=107 samples; GSE41850, n=140 samples). Measure all performance metrics.
PHASE 4 — Distributed Network Simulation (Days 61–90): Deploy multi-node testbed using Docker/Kubernetes across 3 geographic cloud regions (US-East, EU-West, Asia-Pacific). Simulate adversarial conditions (packet loss 1–5%, latency injection 50–200 ms).
PHASE 5 — Security Audit and Penetration Testing (Days 91–110): Conduct formal security analysis including fuzzing, side-channel timing analysis, and simulated quantum adversary (Grover's algorithm simulation on reduced key sizes).
PHASE 6 — Biological Validity Verification (Days 111–120): Confirm that DGE analysis, pathway enrichment (GSEA), and co-expression network (WGCNA) results are statistically identical pre- and post-encryption/decryption.
- GEO GSE138614: MS peripheral blood mononuclear cell (PBMC) RNA-seq, n=107 (cases/controls), ~15 GB raw FASTQ.
- GEO GSE41850: MS brain lesion microarray, n=140 samples, ~2 GB.
- GEO GSE131282: MS cerebrospinal fluid transcriptomics, n=60, ~8 GB.
- Synthetic RNA-seq: Generated via polyester R package (10,000–50,000 genes, 50–500 samples) for controlled benchmarking — 0 cost.
- NIST PQC Reference Implementation: liboqs v0.8.0+ (open source, Apache 2.0).
- Network simulation environment: GNS3 or Mininet for WAN emulation.
- Reference classical crypto: OpenSSL 3.x with AES-256-GCM and RSA-2048/4096.
- Hardware reference platform: AWS c5.4xlarge (16 vCPU, 32 GB RAM) for reproducibility.
- MS gene signature databases: MSigDB, ImmPort for biological validation.
- Adversarial test suite: NIST Cryptographic Algorithm Validation Program (CAVP) test vectors.
- Data Integrity: SHA-256 checksum match rate = 100% across all 30+ transfer trials (zero bit errors).
- Latency Overhead: PQC latency overhead ≤15% vs. AES-256 baseline (mean across all dataset sizes); upper 95% CI ≤25%.
- Throughput: PQC-encrypted transfer throughput ≥85% of classical baseline (≥850 MB/s on 10 Gbps link).
- Key Operation Speed: Kyber-768 key generation <1 ms, encapsulation <1 ms, decapsulation <1 ms on reference hardware.
- Computational Overhead: CPU utilization increase ≤3× classical for equivalent data volume.
- Scalability: Linear or sub-linear throughput degradation as nodes increase from 2→50 (R² ≥ 0.85 for linear fit).
- Security: Zero timing side-channel vulnerabilities detected; ProVerif formal verification passes; AFL++ fuzzing produces zero critical crashes after 48 hours.
- Biological Validity: DGE gene list Jaccard similarity ≥0.99; fold-change Pearson r ≥0.9999; GSEA NES correlation ≥0.999; WGCNA module membership overlap ≥99%.
- Availability: System uptime ≥99.5% during 30-day continuous operation test.
- Regulatory Alignment: Pipeline demonstrably satisfies HIPAA Technical Safeguard requirements (§164.312).
- Any non-zero bit error rate in decrypted data across ≥2 independent trials → ABORT.
- Latency overhead >50% vs. classical baseline for any dataset size ≥10 GB → FAIL.
- Key operation time >10 seconds per operation on reference hardware → FAIL.
- CPU overhead >10× classical baseline → FAIL (clinically impractical).
- Any critical security vulnerability (CVE-level) discovered during fuzzing or formal analysis → FAIL pending patch.
- DGE analysis Jaccard similarity <0.95 between original and decrypted data → FAIL (data corruption).
- System crashes or data loss in >1% of transfer attempts under normal network conditions → FAIL.
- Throughput <10% of classical baseline → FAIL (operationally unusable).
- Memory consumption >256 GB per node (exceeds available hardware) → FAIL without hardware upgrade.
- ProVerif formal verification identifies authentication bypass → FAIL.
12
GPU hours
120d
Time to result
$3,200
Min cost
$18,500
Full cost
ROI Projection
- Software Licensing: PQC-secured biomedical data transfer platform licensable to pharmaceutical companies, CROs, and hospital networks; estimated TAM $2.3B by 2030 (quantum-safe healthcare IT market).
- SaaS Product: Cloud-based PQC transcriptomic data exchange service; estimated ARR $5–15M within 3 years of launch for mid-tier biotech market.
- Consulting/Implementation: Protocol implementation services for HIPAA-compliant PQC migration; $500K–$2M per enterprise engagement.
- Standards Contribution: Participation in HL7 FHIR quantum-safe extension development; positions organization as standards body contributor.
- Partnership Value: Validated pipeline attractive to AWS HealthLake, Google Cloud Healthcare API, Microsoft Azure Health Data Services for integration; potential $10–50M partnership/acquisition value.
- Insurance/Compliance Market: Quantum-safe certification for biomedical data pipelines; emerging market estimated at $800M by 2028.
- Defense/Government: NIH, DoD, and intelligence community interest in quantum-safe genomic data protection; potential $5–20M in government contracts.
🔓 If proven, this unlocks
Proving this hypothesis is a prerequisite for the following downstream discoveries and applications:
- 1FEDERATED-LEARNING-MS-PQC-SECURED
- 2PQC-GENOMIC-DATA-MARKETPLACE
- 3QUANTUM-SECURE-CLINICAL-TRIAL-NETWORKS
- 4PQC-MULTIOMICS-INTEGRATION-PIPELINE
- 5HIPAA-COMPLIANT-PQC-BIOBANK-PROTOCOL
- 6REAL-TIME-PQC-NEUROIMAGING-TRANSMISSION
Prerequisites
These must be validated before this hypothesis can be confirmed:
- PQC-NIST-STANDARDIZATION-COMPLETE
- MS-TRANSCRIPTOMIC-DATA-ACCESS-APPROVAL
- LIBOQS-STABILITY-VERIFIED
- DISTRIBUTED-COMPUTE-INFRASTRUCTURE-AVAILABLE
- IRB-DATA-USE-AGREEMENT-GSE138614
Implementation Sketch
# PQC Transcriptomic Data Transfer Pipeline # Architecture: Hybrid KEM + Symmetric Encryption + Digital Signature ## SYSTEM ARCHITECTURE """ [Data Source Node] [Transit Layer] [Recipient Node] RNA-seq Data PQC-TLS 1.3 Decryption (FASTQ/BAM/HDF5) --> Kyber-768 KEM --> Verification Chunking (1GB) AES-256-GCM DGE Analysis Dilithium3 Sign gRPC/HTTPS Audit Log """ ## PSEUDOCODE # Step 1: Key Setup (run once per session) def setup_pqc_session(sender_id, receiver_id): # Generate Kyber-768 keypair for receiver receiver_pk, receiver_sk = kyber768.keygen() # Generate Dilithium3 keypair for sender (signing) sender_sign_pk, sender_sign_sk = dilithium3.keygen() # Exchange public keys via authenticated channel # (bootstrapped with classical PKI, migrated to PQC PKI) register_public_key(receiver_id, receiver_pk) register_public_key(sender_id, sender_sign_pk) return sender_sign_sk, receiver_pk # Step 2: Data Preparation def prepare_transcriptomic_data(filepath, chunk_size_gb=1): data = load_genomic_file(filepath) # FASTQ/BAM/HDF5 chunks = split_into_chunks(data, chunk_size_gb * 1024**3) checksums = [sha256(chunk) for chunk in chunks] manifest = create_manifest(filepath, checksums, timestamp=now()) return chunks, manifest # Step 3: Encryption (per chunk) def encrypt_chunk_pqc(chunk, receiver_pk, sender_sign_sk): # KEM: encapsulate shared secret ciphertext_kem, shared_secret = kyber768.encapsulate(receiver_pk) # Derive AES key from shared secret aes_key = hkdf_sha256(shared_secret, salt=os.urandom(32), info=b"MS-transcriptomics-v1", length=32) # Encrypt chunk with AES-256-GCM nonce = os.urandom(12) ciphertext_data, tag = aes_256_gcm_encrypt(aes_key, nonce, chunk) # Sign the encrypted chunk payload = ciphertext_kem + nonce + ciphertext_data + tag signature = dilithium3.sign(payload, sender_sign_sk) # Package encrypted_chunk = { 'kem_ciphertext': ciphertext_kem, # 1088 bytes (Kyber-768) 'nonce': nonce, # 12 bytes 'data_ciphertext': ciphertext_data, # variable 'aes_tag': tag, # 16 bytes 'signature': signature, # 3293 bytes (Dilithium3) 'chunk_id': uuid4(), 'algorithm': 'KYBER768-AES256GCM-DILITHIUM3' } return encrypted_chunk # Step 4: Transmission def transmit_encrypted_dataset(encrypted_chunks, manifest, receiver_endpoint): session = establish_pqc_tls_session(receiver_endpoint) # Send manifest first send_with_retry(session, serialize(manifest), max_retries=3) # Stream chunks with flow control for i, chunk in enumerate(encrypted_chunks): ack = send_with_retry(session, serialize(chunk), max_retries=5) if not ack.success: raise TransmissionError(f"Chunk {i} failed after 5 retries") log_transfer_metric(chunk_id=chunk['chunk_id'], bytes_sent=len(chunk['data_ciphertext']), latency_ms=ack.latency) return TransferReceipt(manifest_hash=sha256(manifest), total_chunks=len(encrypted_chunks)) # Step 5: Decryption and Verification def decrypt_and_verify(encrypted_chunks, receiver_sk, sender_sign_pk, expected_manifest): decrypted_chunks = [] for chunk in encrypted_chunks: # Verify signature first payload = (chunk['kem_ciphertext'] + chunk['nonce'] + chunk['data_ciphertext'] + chunk['aes_tag']) if not dilithium3.verify(payload, chunk['signature'], sender_sign_pk): raise SecurityError(f"Signature verification FAILED chunk {chunk['chunk_id']}") # Decapsulate shared secret shared_secret = kyber768.decapsulate(chunk['kem_ciphertext'], receiver_sk) # Derive AES key aes_key = hkdf_sha256(shared_secret, salt=..., info=b"MS-transcriptomics-v1", length=32) # Decrypt plaintext = aes_256_gcm_decrypt(aes_key, chunk['nonce'], chunk['data_ciphertext'], chunk['aes_tag']) decrypted_chunks.append(plaintext) # Reassemble and verify integrity full_data = reassemble_chunks(decrypted_chunks) verify_manifest_checksums(full_data, expected_manifest) return full_data # Step 6: Biological Validation def validate_biological_integrity(original_path, decrypted_data): original = load_count_matrix(original_path) decrypted = load_count_matrix(decrypted_data) # Bit-level check assert sha256(original) == sha256(decrypted), "INTEGRITY FAILURE" # Biological-level check (DESeq2 via rpy2) dge_original = run_deseq2(original, design="~condition") dge_decrypted = run_deseq2(decrypted, design="~condition") jaccard = compute_jaccard(dge_original.sig_genes, dge_decrypted.sig_genes) pearson_r = correlate(dge_original.log2fc, dge_decrypted.log2fc) assert jaccard >= 0.99, f"Biological validity FAILED: Jaccard={jaccard}" assert pearson_r >= 0.9999, f"Fold-change correlation FAILED: r={pearson_r}" return ValidationReport(jaccard=jaccard, pearson_r=pearson_r, integrity="PASS") ## BENCHMARKING HARNESS def run_benchmark_suite(dataset_sizes_gb=[1, 10, 50, 100], n_trials=10, crypto_modes=['classical', 'pqc']): results = [] for size in dataset_sizes_gb: data = generate_synthetic_rnaseq(size_gb=size) for mode in crypto_modes: for trial in range(n_trials): t_start = time.perf_counter() if mode == 'pqc': encrypted = encrypt_chunk_pqc(data, receiver_pk, sign_sk) transmitted = transmit_encrypted_dataset([encrypted], ...) decrypted = decrypt_and_verify([encrypted], ...) else: encrypted = aes256_encrypt(data) transmitted = transmit_classical(encrypted) decrypted = aes256_decrypt(encrypted) t_end = time.perf_counter() results.append({ 'size_gb': size, 'mode': mode, 'trial': trial, 'latency_s': t_end - t_start, 'throughput_mbps': (size*1024) / (t_end - t_start), 'cpu_pct': psutil.cpu_percent(), 'mem_gb': psutil.virtual_memory().used / 1e9 }) return pd.DataFrame(results) ## DEPLOYMENT CONFIGURATION (docker-compose excerpt) """ services: pqc-sender: image: pqc-transcriptomics:v1.0 environment: - KYBER_SECURITY_LEVEL=768 - DILITHIUM_LEVEL=3 - CHUNK_SIZE_GB=1 - MAX_RETRIES=5 volumes: - /data/rnaseq:/data:ro pqc-receiver: image: pqc-transcriptomics:v1.0 ports: - "8443:8443" # PQC-TLS environment: - VERIFY_SIGNATURES=true - AUDIT_LOG=true """
CHECKPOINT 1 — Day 7 (Data Acquisition Complete): ABORT IF: GEO datasets unavailable or data use agreement denied for >2 of 3 primary datasets. Action: Switch to fully synthetic data only; note limitation in scope.
CHECKPOINT 2 — Day 15 (Baseline Benchmarking Complete): ABORT IF: Classical AES-256 baseline throughput <50 MB/s on reference hardware (indicates infrastructure problem, not cryptographic). Action: Diagnose and fix infrastructure before proceeding.
CHECKPOINT 3 — Day 30 (PQC Unit Testing Complete): ABORT IF: liboqs CAVP test vector validation fails for Kyber-768 or Dilithium3. Action: Downgrade to previous stable liboqs version; file bug report; do not proceed with broken implementation.
CHECKPOINT 4 — Day 40 (Integration Testing — First Data Integrity Check): ABORT IF: Any bit error detected in decrypted output on first 5 integration tests. Action: Full debug of encryption/decryption pipeline before any further testing; this is a hard stop.
CHECKPOINT 5 — Day 55 (Distributed Deployment — 2-Node Test): ABORT IF: 2-node transfer failure rate >5% under normal network conditions. Action: Debug network/protocol layer; do not scale to more nodes until 2-node is stable.
CHECKPOINT 6 — Day 65 (Performance Benchmarking — Preliminary Results): ABORT IF: PQC latency overhead >200% vs. classical baseline for 10 GB dataset. Action: Profile bottlenecks; if fundamental algorithmic limitation (not implementation bug), revise hypothesis scope to smaller datasets only.
CHECKPOINT 7 — Day 80 (Security Analysis — Fuzzing Midpoint): ABORT IF: AFL++ discovers memory corruption vulnerability (heap overflow, use-after-free) in PQC API. Action: Halt all testing; patch vulnerability; restart security phase from Day 76.
CHECKPOINT 8 — Day 90 (Security Analysis Complete): ABORT IF: ProVerif identifies authentication bypass or key compromise in protocol model. Action: Redesign key exchange protocol; this constitutes a fundamental security failure requiring protocol revision before biological validation.
CHECKPOINT 9 — Day 100 (Biological Validity — Preliminary): ABORT IF: DGE Jaccard similarity <0.90 on first biological validation run. Action: Investigate data corruption pathway; if systematic, abort and report as negative result with full methodology.
CHECKPOINT 10 — Day 110 (Full Results Available): GO/NO-GO DECISION: If ≥7 of 10 success criteria are met → proceed to publication. If 4
📡 New evidence since EVP generation
Discoveries published after this EVP was written that relate to its hypothesis or downstream unlocks.
- Related